Business Context and Reporting Period
This Form 8-K reports on events occurring on February 21, 2018, filed by DFB Healthcare Acquisitions Corp. (noted as Adapthealth Corp. in metadata). The registrant is a Delaware corporation and an emerging growth company. The filing details the completion of its Initial Public Offering (IPO) and a concurrent private placement.
Key Financial Metrics
- IPO Proceeds: Sold 25,000,000 Units at $10.00 per Unit, generating gross proceeds of $250,000,000.
- Private Placement Proceeds: Sold 4,333,333 Private Placement Warrants at $1.50 per warrant, generating total proceeds of $6,500,000.
- Total Capital Raised: $256,500,000 (Gross).
- Liquidity/Trust Account: A total of $250,000,000 of net proceeds was deposited into a trust account for public stockholders.
- Operating Metrics: The filing does not provide revenue, profit, cash flow, or margin data as the company is a special purpose acquisition company (SPAC) in its initial formation stage.
Material Changes
There are no prior comparable periods for operating metrics as this represents the company's initial capitalization. The material change is the transition from a private entity to a public company with significant cash liquidity held in trust.
Outlook, Risks, and Unusual Items
Management Commentary: The company has completed its IPO and private placement. An audited balance sheet as of February 21, 2018, reflecting these proceeds, is included as Exhibit 99.1.
Unusual Items: The structure involves Units consisting of one share of common stock and one-third of one warrant. The private placement warrants were sold to specific investors simultaneously with the IPO.
Risks: The filing text does not explicitly list risk factors; however, as an emerging growth company, it is subject to reduced reporting requirements.
Investor Verification Checklist
- Verify the audited balance sheet (Exhibit 99.1) to confirm the exact cash balance and any transaction costs deducted from the gross proceeds.
- Confirm the terms of the Warrants (exercise price, expiration) referenced in the Unit structure.
- Review the trust account agreement to understand the conditions under which the $250,000,000 can be withdrawn or returned to shareholders.
- Check for any underwriting discounts or commissions not explicitly detailed in the gross proceeds summary.